A novel glucose beta‐hydroxybutyrate combination improves hypoglycaemia recovery and patient‐reported outcomes in type 1 diabetes

Ähnliche Einträge

• Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes
  von: Cecilie H. Svensson, et al.
  Veröffentlicht: (2024)
• Improvement in body mass index category was associated with improved cardiometabolic measures and patient‐reported outcomes in adults with type 2 diabetes treated with tirzepatide
  von: Rodolfo J. Galindo, et al.
  Veröffentlicht: (2025)
• Effects of insulin‐induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes
  von: Therese Wilbek Fabricius, et al.
  Veröffentlicht: (2025)
• Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents
  von: Setor K. Kunutsor, et al.
  Veröffentlicht: (2024)
• Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia
  von: Lukas van Baal, et al.
  Veröffentlicht: (2025)